These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 10502254)

  • 41. Serum hepatitis B surface antigen kinetics in severe reactivation of hepatitis B e antigen negative chronic hepatitis B patients receiving nucleoside/nucleotide analogues.
    Wong GL; Chan HL; Lo AO; Chan HY; Tse CH; Chim AM; Wong VW
    Antivir Ther; 2013; 18(8):979-86. PubMed ID: 23744529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
    Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
    Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients.
    Yeo W; Ho WM; Hui P; Chan PK; Lam KC; Lee JJ; Johnson PJ
    Breast Cancer Res Treat; 2004 Dec; 88(3):209-15. PubMed ID: 15609123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
    Huang H; Cai Q; Lin T; Lin X; Liu Y; Gao Y; Peng R
    Expert Opin Pharmacother; 2009 Oct; 10(15):2399-406. PubMed ID: 19761353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunosuppression and HBV reactivation.
    Shouval D; Shibolet O
    Semin Liver Dis; 2013 May; 33(2):167-77. PubMed ID: 23749673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy--pathogenesis and management.
    Xunrong L; Yan AW; Liang R; Lau GK
    Rev Med Virol; 2001; 11(5):287-99. PubMed ID: 11590667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The efficacy of lamivudine prophylaxis against hepatitis B reactivation in breast cancer patients undergoing chemotherapy: a meta-analysis.
    Liu JY; Sheng YJ; Ding XC; Tang H; Tong SW; Zhang DZ; Zhou Z; Hu P; Liao Y; Ren H; Hu HD
    J Formos Med Assoc; 2015 Feb; 114(2):164-73. PubMed ID: 25678179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: a 4-year experience.
    Liu CJ; Lai MY; Lee PH; Chou NK; Chu SH; Chen PJ; Kao JH; Jen YM; Chen DS
    J Gastroenterol Hepatol; 2001 Sep; 16(9):1001-8. PubMed ID: 11595064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience.
    Papadopoulos N; Deutsch M; Manolakopoulos S; Bitsi C; Michalakeas H; Poulakidas H; Tsironi E; Giannouli S; Papatheodoridis GV; Koskinas J; Pectasides D
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):56-60. PubMed ID: 27669175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential roles of serum hepatitis B virus DNA and hepatitis B surface antigen level in predicting virological breakthrough in patients receiving lamivudine therapy.
    Su CW; Wu CY; Hung HH; Wu CH; Sheen IJ; Wu JC
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1849-58. PubMed ID: 23730852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Virological response to different combination regimes of peginterferon alpha-2b and lamivudine in hepatitis B e antigen positive chronic hepatitis B.
    Chan HL; Wong VW; Chim AM; Choi PC; Chan HY; Hui AY; Wong GL; Sung JJ
    Antivir Ther; 2007; 12(5):815-23. PubMed ID: 17713165
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy.
    Loomba R; Rowley A; Wesley R; Liang TJ; Hoofnagle JH; Pucino F; Csako G
    Ann Intern Med; 2008 Apr; 148(7):519-28. PubMed ID: 18378948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
    Lau GK; Piratvisuth T; Luo KX; Marcellin P; Thongsawat S; Cooksley G; Gane E; Fried MW; Chow WC; Paik SW; Chang WY; Berg T; Flisiak R; McCloud P; Pluck N;
    N Engl J Med; 2005 Jun; 352(26):2682-95. PubMed ID: 15987917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B.
    Lim SG; Wai CT; Rajnakova A; Kajiji T; Guan R
    Gut; 2002 Oct; 51(4):597-9. PubMed ID: 12235087
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HBsAg seroclearance in Chinese patients receiving lamivudine therapy for chronic hepatitis B virus infection.
    Yuen MF; Wong DK; Yuan HJ; Sum SM; Lai CL
    J Clin Microbiol; 2004 Oct; 42(10):4882-4. PubMed ID: 15472371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.
    Hou J; Yin YK; Xu D; Tan D; Niu J; Zhou X; Wang Y; Zhu L; He Y; Ren H; Wan M; Chen C; Wu S; Chen Y; Xu J; Wang Q; Wei L; Chao G; Constance BF; Harb G; Brown NA; Jia J
    Hepatology; 2008 Feb; 47(2):447-54. PubMed ID: 18080339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Entecavir 1mg versus combined lamivudine/adefovir dipivoxil in chronic HBV Egyptian patients resistant to LAM monotherapy, non-randomised controlled study.
    Maklad S; Doss W; El Din SS; Hassan K; Zeid AA
    Arab J Gastroenterol; 2014 Mar; 15(1):1-5. PubMed ID: 24630505
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection.
    Cho JH; Lim JH; Park GY; Kim JS; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
    Transpl Infect Dis; 2014 Apr; 16(2):295-303. PubMed ID: 24628837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy.
    Law MF; Ho R; Cheung CK; Tam LH; Ma K; So KC; Ip B; So J; Lai J; Ng J; Tam TH
    World J Gastroenterol; 2016 Jul; 22(28):6484-500. PubMed ID: 27605883
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients.
    Lim LL; Wai CT; Lee YM; Kong HL; Lim R; Koay E; Lim SG
    Aliment Pharmacol Ther; 2002 Nov; 16(11):1939-44. PubMed ID: 12390103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.